(Q34680333)

3 August 2017

1 reference

title

The medicinal chemistry of multidrug resistance (MDR) reversing drugs (English)

1 reference

3 August 2017

multiple drug resistance

1 reference

E Teodori

1

1 reference

3 August 2017

S Dei

series ordinal

2

1 reference

3 August 2017

S Scapecchi

series ordinal

3

1 reference

3 August 2017

F Gualtieri

series ordinal

4

1 reference

3 August 2017

language of work or name

1 reference

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

57

1 reference

3 August 2017

385-415

1 reference

3 August 2017

5

1 reference

Causes and problems of nonresponse or poor response to drugs.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

7 January 2021

Multiple drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

What's new in cytostatic drug resistance and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Ceramide glycosylation potentiates cellular multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The involvement of sphingolipids in multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Function, evolution and structure of multidrug resistance protein (MRP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Kinetics of the multidrug transporter (P-glycoprotein) and its reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The P-glycoprotein efflux pump: how does it transport drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Dissection of drug-binding-induced conformational changes in P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Merck Frosst Award Lecture 1998. Molecular dissection of the human multidrug resistance P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A family of drug transporters: the multidrug resistance-associated proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Pharmacologic circumvention of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Recent developments in overcoming tumour cell multi-drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity relationships of multidrug resistance reversers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Evolutionary relationships among ABC transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A new structural model for P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Symmetry and structure in P-glycoprotein and ABC transporters what goes around comes around

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Determining the structure and mechanism of the human multidrug resistance P-glycoprotein using cysteine-scanning mutagenesis and thiol-modification techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structural, mechanistic and clinical aspects of MRP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Multidrug resistance protein MRP1 reconstituted into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A structure-based mechanism for drug binding by multidrug transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A novel hypothesis for the mechanism of action of P-glycoprotein as a multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Indirect mechanism of drug transport by P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

P-glycoprotein--a mediator of multidrug resistance in tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The multidrug resistance (mdr1) gene product functions as an ATP channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The (patho)physiological functions of the MRP family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Multiple physiological functions for multidrug transporter P-glycoprotein?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

ABC transporters: bacterial exporters-revisited five years on.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The physiological function of drug-transporting P-glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The secretory function of the liver: new aspects of hepatobiliary transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Multidrug resistance in cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Doxorubicin-peptide conjugates overcome multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Future perspectives for the development of P-glycoprotein modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Calcein accumulation as a fluorometric functional assay of the multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Pharmacological considerations in the modulation of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Bromocriptine modulates P-glycoprotein function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Cholesterol interaction with the daunorubicin binding site of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

P-glycoprotein inhibition by glibenclamide and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Design, synthesis, and evaluation of the multidrug resistance-reversing activity of D-glucose mimetics of hapalosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of P-glycoprotein activity and chemosensitization of multidrug-resistant ovarian carcinoma 2780AD cells by hexanoylglucosylceramide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Multidrug-resistance modulators from Stephania japonica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

HMG-CoA reductase inhibitors and P-glycoprotein modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Isolation of a multidrug resistance inhibitor from Aconitum pseudo-laeve var. erectum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

(-)-Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Staurosporine derivatives reverse multidrug resistance without correlation with their protein kinase inhibitory activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of Multidrug Resistance by Valinomycin is Overcome by CCCP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Clinical reversal of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Comparative in vitro evaluation of dithiane analogs of tiapamil, Ro 11-2933, Ro 44-5911 and Ro 44-5912 as multidrug resistance modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance by verapamil analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Novel multidrug resistance reversal agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Newly synthesized dihydropyridine derivatives as modulators of P-glycoprotein-mediated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and structure--activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Clinical trials of agents that reverse multidrug resistance. A literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and activity against multidrug resistance in Chinese hamster ovary cells of new acridone-4-carboxamides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

New triazine derivatives as potent modulators of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

2,4,5-Trisubstituted imidazoles: novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

2,4,5-Trisubstituted imidazoles: novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

3D-QSAR analysis of 2,4,5- and 2,3,4,5-substituted imidazoles as potent and nontoxic modulators of P-glycoprotein mediated MDR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance by an immunosuppressive agent FK-506

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Derivatives of a novel cyclopeptolide. 1. Synthesis, antifungal activity, and structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Derivatives of a Novel Cyclopeptolide. 2. Synthesis, Activity against Multidrug Resistance in CHO and KB Cells in vitro, and Structure-Activity Relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Valspodar: current status and perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Total synthesis of dendroamide A, a novel cyclic peptide that reverses multiple drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Aureobasidins as new inhibitors of P-glycoprotein in multidrug resistant tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Taxuspines A ∼ C, new taxoids from Japanese yew Taxus cuspidata inhibiting drug transport activity of P-glycoprotein in multidrug-resistant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Modulation of multidrug resistance by taxuspine C and other taxoids from Japanese yew

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of P-glycoprotein and multidrug-resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine K.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Modulation of multidrug resistance in tumor cells by taxinine derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

New taxanes as highly efficient reversal agents for multi-drug resistance in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis of C-ring aromatic taxoids and evaluation of their multi-drug resistance reversing activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and evaluation of artificial taxoids with antitumor and multi-drug resistance reversing activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Studies on propafenone-type modulators of multidrug-resistance IV1): synthesis and pharmacological activity of 5-hydroxy and 5-benzyloxy derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Studies on propafenone-type modulators of multidrug resistance VI. Synthesis and pharmacological activity of compounds with varied spacer length between the central aromatic ring and the nitrogen atom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and pharmacological activity of the stereoisomers of GP-88, a propafenone-type modulator of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of anticancer multidrug resistance by the ardeemins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A new route toward 4-substituted pyrazino[2,1-b]quinazoline-3,6-dione systems. Total synthesis of glyantrypine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Total Synthesis of 5-N-Acetylardeemin and Amauromine: Practical Routes to Potential MDR Reversal Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Euphosalicin, a new diterpene polyester with multidrug resistance reversing activity from Euphorbia salicifolia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Torilin, a Sesquiterpene fromTorilis japonica, Reverses Multidrug-Resistance in Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

New Natural Sesquiterpenes as Modulators of Daunomycin Resistance in a Multidrug-ResistantLeishmaniatropicaLine‖,⊥

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Sesquiterpene Esters fromCelastrus orbiculatusand Their Structure−Activity Relationship on the Modulation of Multidrug Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

New multidrug resistance modulators from Atractylodis Lanceae Rhizoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure of a novel multidrug resistance modulator, irciniasulfonic acid, isolated from a marine sponge, Ircinia sp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and preliminary analysis of a P-glycoprotein-specific [3H]-benzophenone photoaffinity label based on (-)-stipiamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The synthesis and evaluation of a solution phase indexed combinatorial library of non-natural polyenes for reversal of P-glycoprotein mediated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance in human carcinoma cell line by agosterols, marine spongean sterols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and evaluation of 4-deacetoxyagosterol A as an MDR-modulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Photoaffinity analogs for multidrug resistance-related transporters and their use in identifying chemosensitizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Photoaffinity substrates for P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Study of P-glycoprotein functionality in living resistant K562 cells after photolabeling with a verapamil analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

A New Paclitaxel Photoaffinity Analog with a 3-(4-Benzoylphenyl)propanoyl Probe for Characterization of Drug-Binding Sites on Tubulin and P-Glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The quinoline-based drug, N-[4-[1-hydroxy-2-(dibutylamino)ethyl] quinolin-8-yl]-4-azidosalicylamide, photoaffinity labels the multidrug resistance protein (MRP) at a biologically relevant site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and use of a biotinylated 3-azidophenothiazine to photolabel both amino- and carboxyl-terminal sites in calmodulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Synthesis and binding properties of photoactivable biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The human multidrug resistance-associated protein (MRP) gene family: from biological function to drug molecular design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Does P-glycoprotein play a role in anticancer drug pharmacokinetics?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Activity of various amphiphilic agents in reversing multidrug resistance of L 1210 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Reversal of multidrug resistance by phenothiazines and structurally related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Quantitative structure-activity relationship of multidrug resistance reversal agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Resistance to anticancer drugs: are we ready to use biologic information for the treatment of patients with cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Role of transport proteins in drug absorption, distribution and excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

beta-Amyloid efflux mediated by p-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

Resistance mechanisms and their regulation in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2802%2901229-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-827X(02)01229-6

1 reference

3 August 2017

1 reference